BlueRock Therapeutics Competitors and Similar CompaniesClear all
ACADIA Pharmaceuticals's competitors and similar companies include Regenxbio.
 ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Regenxbio Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases. | |
Founding Date | Founding Date 1993 | Founding Date 2009 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Princeton, US | Locations Rockville, US HQ |
Employees | Employees 513 | Employees 4018% increase |
Valuation ($) | Valuation ($) 2.4 b | Valuation ($) 447.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $170.4m (FY, 2025) |
Net income | Net income $391m (FY, 2025) | Net income ($193.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 770.8m | Total funding raised $ 118.9m |
For sources of this data, please see the company profile
View Company Profiles
Regenxbio
HQ
Rockville, US
Employees
401↑ 8% increase
Regenxbio is a clinical-stage biotechnology company providing gene therapy product candidates for the treatment of retinal, metabolic, and neurodegenerative diseases.
View company